| CDK4/6 Inhibitors in Combination With Hormone Therapy for HR/HER2 Advanced Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. | |
| Deng Yunfu; Ma Guangzhi; Li Wen; Wang Ting; Zhao Yaqin; Wu Qiang | |
| 刊名 | Clinical breast cancer
 |
| 2018 | |
| 关键词 | Cohort studies Hazard ratio Meta-regression analysis Prognosis Relative risk |
| ISSN号 | 1938-0666 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/1870699 |
| 专题 | 四川大学 |
| 作者单位 | 1.com. 2.Cancer Center, Sichuan University, Chengdu, China. Department of Thoracic Surgery, Sichuan University, Chengdu, China. Cancer Center, Sichuan University, Chengdu, China. Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Cancer Center, Sichuan University, Chengdu, China. Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Electronic address: wuqiang818@ |
| 推荐引用方式 GB/T 7714 | Deng Yunfu,Ma Guangzhi,Li Wen,et al. CDK4/6 Inhibitors in Combination With Hormone Therapy for HR/HER2 Advanced Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.[J]. Clinical breast cancer,2018. |
| APA | Deng Yunfu,Ma Guangzhi,Li Wen,Wang Ting,Zhao Yaqin,&Wu Qiang.(2018).CDK4/6 Inhibitors in Combination With Hormone Therapy for HR/HER2 Advanced Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials..Clinical breast cancer. |
| MLA | Deng Yunfu,et al."CDK4/6 Inhibitors in Combination With Hormone Therapy for HR/HER2 Advanced Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.".Clinical breast cancer (2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论